Page last updated: 2024-09-03

imatinib mesylate and Pulmonary Arterial Remodeling

imatinib mesylate has been researched along with Pulmonary Arterial Remodeling in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's5 (83.33)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Akaki, K; Asano, R; Hia, F; Inagaki, T; Ishibashi, T; Ishibashi-Ueda, H; Manabe, Y; Masaki, T; Mino, T; Mori, H; Morinobu, A; Morita, S; Nakaoka, Y; Nakatsuka, Y; Ogo, T; Okazawa, M; Sato, A; Takeuchi, O; Tsujimura, T; Uehata, T; Vandenbon, A; Yaku, A; Yoshinaga, M1
Chen, X; Cheng, Y; Cui, Z; Jia, S; Liang, S; Shen, T; Si, G; Song, S; Yu, H; Yu, X; Zhang, J; Zhang, X1
Higuchi, M; Hikasa, Y; Leong, ZP; Okida, A; Yamano, Y1
Bálint, Z; Dahal, BK; Kwapiszewska, G; Murmann, K; Schermuly, RT; Seeger, W; Veith, C; Weissmann, N; Wygrecka, M; Zakrzewicz, D1
Alavian, KN; Ashek, A; Bozorgi, S; Busbridge, M; Cotroneo, E; Dubois, O; Wang, L; Wharton, J; Wilkins, MR; Zhao, L1
Liu, Y; Ma, C; Shen, T; Song, S; Yi, Z; Yu, L; Yu, X; Zhang, C; Zhang, H; Zhang, M; Zheng, X; Zhu, D1

Other Studies

6 other study(ies) available for imatinib mesylate and Pulmonary Arterial Remodeling

ArticleYear
Regnase-1 Prevents Pulmonary Arterial Hypertension Through mRNA Degradation of Interleukin-6 and Platelet-Derived Growth Factor in Alveolar Macrophages.
    Circulation, 2022, 09-27, Volume: 146, Issue:13

    Topics: Animals; Biomarkers; Cytokines; Familial Primary Pulmonary Hypertension; Hypertension, Pulmonary; Imatinib Mesylate; Interleukin 1 Receptor Antagonist Protein; Interleukin-1beta; Interleukin-6; Leukocytes, Mononuclear; Macrophages, Alveolar; Mice; Platelet-Derived Growth Factor; Pulmonary Arterial Hypertension; Pulmonary Artery; Ribonucleases; RNA Stability; Vascular Remodeling

2022
PDGF-BB/KLF4/VEGF Signaling Axis in Pulmonary Artery Endothelial Cell Angiogenesis.
    Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 2017, Volume: 41, Issue:6

    Topics: Animals; Becaplermin; Cell Hypoxia; Cell Movement; Cell Proliferation; Endothelial Cells; G1 Phase Cell Cycle Checkpoints; Imatinib Mesylate; Indoles; Kruppel-Like Factor 4; Kruppel-Like Transcription Factors; Lung; Male; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-sis; Pulmonary Artery; Pyrroles; Rats; Rats, Wistar; RNA Interference; Signal Transduction; Sunitinib; Up-Regulation; Vascular Endothelial Growth Factor A; Vascular Remodeling

2017
Reversal effects of low-dose imatinib compared with sunitinib on monocrotaline-induced pulmonary and right ventricular remodeling in rats.
    Vascular pharmacology, 2018, Volume: 100

    Topics: Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Extracellular Signal-Regulated MAP Kinases; Gene Expression Regulation; Heart Ventricles; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Imatinib Mesylate; Indoles; Male; Monocrotaline; Nestin; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-raf; Pulmonary Artery; Pyrroles; Rats, Wistar; Receptor, Fibroblast Growth Factor, Type 1; Receptor, Platelet-Derived Growth Factor beta; Signal Transduction; Sunitinib; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2; Vascular Remodeling; Ventricular Function, Right; Ventricular Remodeling

2018
Hypoxia- or PDGF-BB-dependent paxillin tyrosine phosphorylation in pulmonary hypertension is reversed by HIF-1α depletion or imatinib treatment.
    Thrombosis and haemostasis, 2014, Volume: 112, Issue:6

    Topics: Active Transport, Cell Nucleus; Animals; Antihypertensive Agents; Apoptosis; Becaplermin; Benzamides; Cell Adhesion; Cell Proliferation; Cells, Cultured; Disease Models, Animal; Humans; Hypertension, Pulmonary; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Imatinib Mesylate; Mice, Inbred C57BL; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Paxillin; Phosphorylation; Piperazines; Proto-Oncogene Proteins c-sis; Pulmonary Artery; Pyrimidines; Receptor, Platelet-Derived Growth Factor beta; RNA Interference; Signal Transduction; Time Factors; Transfection; Tyrosine; Vascular Remodeling

2014
Iron homeostasis and pulmonary hypertension: iron deficiency leads to pulmonary vascular remodeling in the rat.
    Circulation research, 2015, May-08, Volume: 116, Issue:10

    Topics: Animals; Antihypertensive Agents; Arterial Pressure; Benzamides; Cell Proliferation; Deficiency Diseases; Dichloroacetic Acid; Disease Models, Animal; Erythropoiesis; Ferric Compounds; Ferritins; Glycolysis; Hematinics; Homeostasis; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Imatinib Mesylate; Iron; Iron Deficiencies; Liver; Male; Maltose; Piperazines; Pulmonary Artery; Pyrimidines; Rats, Sprague-Dawley; Signal Transduction; Time Factors; Transferrin; Vascular Remodeling

2015
The role of PDGF-B/TGF-β1/neprilysin network in regulating endothelial-to-mesenchymal transition in pulmonary artery remodeling.
    Cellular signalling, 2016, Volume: 28, Issue:10

    Topics: Animals; Cattle; Cell Hypoxia; Down-Regulation; Endothelial Cells; Endothelium; Hypertension, Pulmonary; Imatinib Mesylate; Immunoprecipitation; Mesoderm; Monocrotaline; Neprilysin; Proto-Oncogene Proteins c-sis; Pulmonary Artery; Rats; Signal Transduction; Transforming Growth Factor beta1; Vascular Remodeling

2016